Cardiac Science, the wholly-owned subsidiary of Opto Circuits India, has been awarded a contract to deploy Powerheart AEDs in all Tyco Flow Control facilities globally.

Tyco Flow Control is a $3.4 billion division of Tyco International. The first phase of the rollout, planned for the first quarter of 2011, will equip Tyco’s Australian, Pacific, and North and South American facilities.

The Opto subsidiary is a global leader in automated external defibrillator (AED) and diagnostic cardiac monitoring devices.

According to Dave Marver, chief executive officer, Cardiac Science, Tyco’s decision reinforces our status as a global leader in AED technology and services.

“We wanted a fully automatic defibrillator that did not require the user to push a button for shock delivery and an AED that customizes the energy level for each patient,” said Ralf Schnörringer, director of Environmental Health and Safety, Tyco Flow Control.

“Cardiac Science’s ability to deliver a globally standardized product and AED programme management throughout the world made them our first choice for the ‘Save a Life’ initiative at Tyco Flow Control.